DF 2755A
Alternative Names: DF-2755ALatest Information Update: 28 Nov 2022
At a glance
- Originator Dompe Farmaceutici
- Class Analgesics
- Mechanism of Action Interleukin 8A receptor antagonists; Interleukin 8B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammatory pain; Postoperative pain
Most Recent Events
- 28 Nov 2022 No recent reports of development identified for phase-I development in Inflammatory-pain(In volunteers) in France (PO, Capsule)
- 28 Nov 2022 No recent reports of development identified for phase-I development in Postoperative-pain(In volunteers) in France (PO, Capsule)
- 29 Jun 2019 Dompé Farmaceutici terminates a phase I trial in Inflammatory and Postoperative pain (In volunteers) in France (PO) due to sponsor decision (NCT04803396)